Archives June 2019

China urged to abandon plan to sell unproven cell therapies

An international stem-cell body says the country’s proposed law could put patients at risk. An international group of stem-cell researchers is urging China to cancel draft regulations that would permit some hospitals to sell therapies developed from patients’ own cells, without approval from the nation’s drug regulator. The International Society for Stem Cell Research (ISSCR) sent a

Read More


3D Printing at Work to Heal Spinal Cord Injury

For people whose spinal cords are injured in traffic accidents, sports mishaps, or other traumatic events, cell-based treatments have emerged as a potential avenue for encouraging healing. Now, taking advantage of advances in 3D printing technology, researchers have created customized implants that may boost the power of cell-based therapies for repairing injured spinal cords. Made of

Read More


Reproducible, miniature 3D models of human brain tissue open new frontiers in neuroscience

esearchers have made a major advance in the development of human brain “organoids” — miniature, 3D tissue cultures that model brains in a dish. The new method, published in Nature, consistently grows the same types of cells, in the same order, as the developing human cerebral cortex. The advance could change the way researchers study neuropsychiatric

Read More


EU awards 742 million euro to 1,062 Israeli science projects

Special recognition award given to 423 Israeli companies and researchers that won the Horizon 2020 grant in 2018. The EU Delegation to Israel, together with the Israel-Europe Research and Innovation Directorate (ISERD) and the Israel Innovation Authority, celebrated scientific cooperation under the Horizon 2020 program with an awards ceremony on June 4th at the Peres

Read More


Austria: Admissibility Of Stem Cell Therapy – Case Law Update Austria

In a recent decision (Ra 2015/11/0113), the Austrian Supreme Administrative Court (VwGH) inter aliaaddressed the question whether the application of stem cell therapy violates Section 49 of the Austrian Act on the Medical Profession (Ärztegesetz, ÄrzteG), which requires physicians to treat patients “… in accordance with state of the art medical science and practice” and to at all

Read More


Gene Therapy: Commercial Challenges And Strategic Choices

Source BIOPROCESS ONLINE Innovation in gene therapy brings the potential for transforming patient care and obviating the need for chronic therapy through single-dose cures. Despite the potential long-term benefits of this new therapeutic modality, gene therapy companies face a number of underappreciated challenges. While there have been recent curative achievements in hepatitis C virus, curative

Read More


FDA approves first treatment for episodic cluster headache that reduces the frequency of attacks

The U.S. Food and Drug Administration today approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.  “Emgality provides patients with the first FDA-approved drug that reduces the frequency of attacks of episodic cluster headache, an extremely painful and often debilitating condition,” said Eric Bastings, M.D., deputy director of the

Read More